Time to capitalise on higher yields

The docile bond market of the past 20+ years is gone. As many professional managers, allocators and advisors have been burned this past year, we expected underperformance but are now in the process of capitalising on higher yields. Whilst risks to rates and credit spreads remain, the possibility of moving up the capital structure (i.e. lower risk) to get a near equivalent income return (i.e. equity to debt, AT1 hybrid to Tier 2 bond, senior to covered) is a clear sign to accumulate in a misunderstood and underappreciated local asset class. 

Big super and our sovereign wealth funds are quickly increasing their bond allocations, investors should be seriously considering this also.

Hell hath no fury like the bond market scorned

Bond vigilantes have emerged from deep hibernation, forcing British bonds, also known as Gilts, to yield levels not seen since the GFC. The 2-year Gilt has risen +175bps in the past five days (all article data as of 10am 27-September 2022 unless otherwise stated). This is an upwards move without parallel, going back to 1992. The 2-year Gilt now yields 4.5%, at the start of the year this was 0.4%.     

Furthermore, the Pound Sterling has dropped to its lowest level on record against the dollar (last: GBPUSD 1.077). These moves have been caused by the dilemma facing policy makers: drive growth through fiscal expansion but risk embedding inflation; or allow growth to nosedive, unemployment to increase and inflation to deflate. The new UK government has revealed an enormous stimulus plan to punt on growth, a noble bet, but foolish through our lens, given the Bank of England expects inflation to continue increasing to 11% in October this year. 

These moves, in addition to Fed decisions last week, have seen our local bond yields correspondingly move upwards. As of this morning (27/9/22) our 3mBBSW, 2y and 10y yields are respectively 3.02%, 3.53% and 4.05%. The AusBond Composite Index, APRA’s local fixed income benchmark for superannuation is now -1.89% month to date (mtd, as of 26/9/22) and -10.52% year to date (ytd).    

Credit where its due

The biggest story in credit is currently the buyout and associated financing of Citrix Systems (NASDAQ: CTXS), where banks have lost ~US$600 million in underwriting the deal. The majority of these losses were associated with the US$4 billion secured bond portion of the funding package. The bonds eventually priced at a yield of around 10% and price discount of ~84 cents on the dollar.

When simplified, it is typical in the US leveraged buyout (LBO) market for banks to commit to financing for private equity sponsors in the months before a deal closes. Once finalised, the banks then offload these commitments to the loan and bond market. If pricing moves the wrong way, banks are forced to offer price discounts to entice investors.

Those with longer memories will recall the big losses banks were forced to take in the GFC under such circumstances. As Figure 2 illustrates, funding costs have not shown any real relief this year in high yield. Further losses on funding deals to banks this year include Intertape and Entegris which collectively totalled $85 million.

The key takeaway is that higher financing costs are placing greater pressure on banks seeking to offload commitments. This casts an ominous shadow on the LBO market and ultimately will drive higher volatility in high yield credit spreads across loans and bonds.

The difficult issuance environment, where US and EU yields on CCC bonds have been above 10% since May (see Figure 3) – a distinct measure of stress, is being compounded by an outflow of redemptions in mutual funds and ETFs due to weak performance (see Figure 4) and cross-asset rebalancing.

Taking a brief tangent to funding stress, the TED spread, which we discussed here, has increased markedly in the past week to be closing in on highs seen earlier this year. As seen in Figure 5, whilst we are leaps and bounds away from GFC levels, it does speak to further anecdotes of funding and liquidity becoming more front of mind. A local example here is Zip Co (ASX: ZIP), which yesterday brought to the securitisation market a 13-month Master Trust ABS, of which the A1 tranche (AAA credit rating) had pricing guidance of +195bps, the A2 tranche (also AAA credit rating) had pricing guidance of +315bps and the F tranche, with a B credit rating had pricing guidance of +1,250bps. At these prices we are beginning to question when the equity funding model breaks down here - and if this is just a risk transfer trade.

Offshore loan prices saw their biggest drop in almost three months on Friday and Metrics Master Income Trust (ASX: MXT) also saw its biggest price drop in three months yesterday (notably, the NAV did not fall on a clean basis). This spurred us to compare the traded unit price of MXT to the US loan market on a price basis. Whilst there are several structural reasons as to why such comparison is not apples-for-apples (dirty vs clean, different legal frameworks for creditors, differing underlying exposures, differing security and covenants), we note that since September 2019 there has been a strong relationship here.

We think this relationship lacks fundamental merit; it is nonetheless a traded dynamic that is somewhat understandable given the proxy-like nature. Indeed, as illustrated on Figure 7, the relationship when scaled to adjust for different pricing, provides a strong tool for assessing value and therefore a signal to buy and sell.

Whilst this is similar in signal to a pure comparison to MXT’s net asset value, it provides a traded market overlay, which we see as useful from an opportunity cost perspective. We note this relationship has turned negative yesterday – indicating relative levels of cheapness (albeit moderate). 

Locally, our corporate credit funding costs have returned to 5-year highs. Spreads have moderated, particularly in financials, meaning the driver of higher funding costs have been higher risk-free rates. Such levels now for investors are getting too cheap to ignore, especially relative to an ASX200 dividend yield of 5.08% - effectively the same as the yield on an investment grade bond – but for far less volatility and market risk.

Emphasising this point is Figure 9, which is illustrating that compensation for interest rate risk is at levels not seen in the prior 5-years. For reference, the AusBond Credit 1-5-year index is yielding 5.01% with a modified duration of 2.76. For those with more aggressive duration mandates, the 5-7-year index is yielding 5.7% for a modified duration of 5.13. Most importantly, for those that don’t want any duration, or interest rate risk, the AusBond Credit floating-rate note index is yielding 4.59%. 

Bonds are back. Fear is creating opportunities for the informed, the likes of which has not seen in decades.

BondAdviser has acted on information provided to it and our research is subject to change based on legal offering documents. This research is for informational purposes only. This information discusses general market activity, industry or sector trends, or other broad-based economic, market or political conditions and should not be construed as research or investment advice. The content of this report is not intended to provide financial product advice and must not be relied upon as such. The Content and the Reports are not and shall not be construed as financial product advice. The statements and/or recommendations on this web application, the Content and/or the Reports are our opinions only. We do not express any opinion on the future or expected value of any Security and do not explicitly or implicitly recommend or suggest an investment strategy of any kind. The content and reports provided have been prepared based on available data to which we have access. Neither the accuracy of that data nor the methodology used to produce the report can be guaranteed or warranted. Some of the research used to create the content is based on past performance. Past performance is not an indicator of future performance. We have taken all reasonable steps to ensure that any opinion or recommendation is based on reasonable grounds. The data generated by the research is based on methodology that has limitations; and some of the information in the reports is based on information from third parties. We do not guarantee the currency of the report. If you would like to assess the currency, you should compare the reports with more recent characteristics and performance of the assets mentioned within it. You acknowledge that investment can give rise to substantial risk and a product mentioned in the reports may not be suitable to you. You should obtain independent advice specific to your circumstances, make your own enquiries and satisfy yourself before you make any investment decisions or use the report for any purpose. This report provides general information only. There has been no regard whatsoever to your own personal or business needs, your individual circumstances, your own financial position or investment objectives in preparing the information. We do not accept responsibility for any loss or damage, however caused (including through negligence), which you may directly or indirectly suffer in connection with your use of this report, nor do we accept any responsibility for any such loss arising out of your use of, or reliance on, information contained on or accessed through this report. © 2022 Bond Adviser Pty Ltd. All rights reserved.

3 stocks mentioned

Charlie Callan
Associate Director

Charlie is an Associate Director and Investment Committee member at BondAdviser. His focus is buy-side coverage in Australian fixed income, across both the capital structure and credit fundamentals.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.


Sign In or Join Free to comment